Akums Drugs and Pharmaceuticals informs about annual secretarial compliance report

17 May 2025 Evaluate
Akums Drugs and Pharmaceuticals has informed that it enclosed the Annual Secretarial Compliance Report of the Company for the financial year ended 31st March, 2025, issued by, Kavita, Partner of A. K. Nandwani & Associates, the Secretarial Auditor of the Company.

The above information is a part of company’s filings submitted to BSE.

Akums Drugs & Pharma Share Price

466.05 -8.80 (-1.85%)
30-Mar-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1757.35
Dr. Reddys Lab 1254.65
Cipla 1223.05
Zydus Lifesciences 871.20
Lupin 2312.70
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×